{"title": "Anti-inflammatory drug is the key to boosting cardiac reprogramming", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/heart_disease.xml", "value": "Anti-inflammatory drug is the key to boosting cardiac reprogramming"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190306100604.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190306100604.htm", "summary": "Researchers have developed a high-throughput screening system to identify the NSAID diclofenac as a factor responsible for enhancing cardiac reprogramming in postnatal and adult fibroblasts. Diclofenac functioned during early-stage reprogramming by silencing the cellular signature associated with fibroblasts and inhibiting COX-2 and other molecules associated with inflammation. Ant-inflammation could therefore be used to improve cardiac reprogramming associated with aging.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/heart_disease.xml", "value": "Researchers have developed a high-throughput screening system to identify the NSAID diclofenac as a factor responsible for enhancing cardiac reprogramming in postnatal and adult fibroblasts. Diclofenac functioned during early-stage reprogramming by silencing the cellular signature associated with fibroblasts and inhibiting COX-2 and other molecules associated with inflammation. Ant-inflammation could therefore be used to improve cardiac reprogramming associated with aging."}, "published": "Wed, 06 Mar 2019 10:06:04 EST", "published_parsed": [2019, 3, 6, 15, 6, 4, 2, 65, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190306100604.htm", "guidislink": false}